Submitted by Anonymous (not verified) on 19 April 2024 - 14:30
Human medicines European public assessment report (EPAR): Cyramza, ramucirumab, Date of authorisation: 19/12/2014, Revision: 17, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Cyramza, ramucirumab, Date of authorisation: 19/12/2014, Revision: 17, Status: Authorised